Financials
- Market Capitalization 10.44 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3 449
市销率
5.56
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 878 | KRYS Krystal Biotech, Inc. - Common Stock | 363.44 USD | -0.65% | -3.21% | +14.29% | +94.22% | 10.71 B USD | ||
| 881 | ABVX Abivax SA - American Depositary Shares | 135.98 USD | -2.80% | -4.58% | +36.53% | +1410.89% | 10.68 B USD | ||
| 906 | CYTK Cytokinetics, Incorporated - Common Stock | 82.24 USD | -3.10% | -4.47% | +17.23% | +41.55% | 10.23 B USD | ||
| 924 | NUVL Nuvalent, Inc. - Class A Common Stock | 123.94 USD | +0.03% | +0.19% | +0.52% | +30.53% | 9.79 B USD |